Moving Forward, Together: Research Update and Emerging Therapies for Parkinson's (2020)

Dr. Jonathan Stoessl, Head of Neurology at the University of British Columbia, addressed Parkinson's disease challenges in this talk, stressing the necessity of biomarkers for diagnosis, early detection, and disease monitoring. He presented alpha-synuclein and neurofilament light as potential biomarkers, alongside imaging techniques predicting cognitive impairment in Parkinson's.

The webinar discussed MRI findings like perivascular spaces' predictive value for cognitive change, cholinergic abnormalities' impact on symptoms, and the role of inflammation in disease progression. Treatment options encompassed levodopa variations, continuous apomorphine infusion, diverse medications managing motor/non-motor symptoms, along with surgical options like deep brain stimulation and MRI-guided focused ultrasound. Lifestyle factors like exercise, diet, and sleep were highlighted for Parkinson's management.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**